Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )
The Notes were issued in December, 2006, in a 144A private placementtransaction and are subject to the terms of a registration rights agreementfiled as an exhibit to the registration statement. The registration statement,while effective, permits selling securityholders to publicly resell thesecurities subject to certain limitations and the satisfaction of theprospectus delivery requirements of the Securities Act of 1933, as amended.
Advertisement
About Beckman Coulter
Beckman Coulter, Inc. based in Fullerton, California, develops,manufactures and markets products that simplify, automate and innovate complexbiomedical tests. More than 200,000 Beckman Coulter systems operate inlaboratories around the world supplying critical information for improvingpatient health and reducing the cost of care. Recurring revenues consisting ofsupplies, test kits, service and operating-type lease payments represent morethan 75 percent of the company's 2006 annual sales of $2.53 billion. For moreinformation, visit www.beckmancoulter.com.
This press release does not constitute an offer to sell or thesolicitation of an offer to buy securities nor shall there be any sale ofthese securities in any state in which such offer, solicitation or sale wouldbe unlawful prior to registration or qualification under the securities lawsof any such state. Any offers of the securities will be made only by means ofa prospectus.Contacts: Mary Luthy, Beckman Coulter, Inc. Corporate Communications Phone: (714) 993-8770 E-mail: [email protected] Robert Raynor, PhD, Beckman Coulter, Inc. Investor Relations Phone: (714) 773-8412 E-mail: [email protected]
SOURCE Beckman Coulter, Inc.
